Singular Genomics Systems, Inc. - Common Stock, par value $0.0001 per share (OMIC)
CUSIP: 82933R308
Q3 2025 13F Holders as of 30 Sep 2025
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 1,000
- Total 13F shares
- 409
- Share change
- +409
- Total reported value
- $6,409
- Price per share
- $15.67
- Number of holders
- 1
- Value change
- +$6,409
- Number of buys
- 1
Quarterly Holders Quick Answers
What is CUSIP 82933R308?
CUSIP 82933R308 identifies OMIC - Singular Genomics Systems, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 82933R308:
Top shareholders of OMIC - Singular Genomics Systems, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| James E. Flynn |
3/4/5
13D/G
|
*Possible Member of 10% Group, 10%+ Owner · Deerfield Mgmt IV, L.P. |
100%
from 13D/G
|
9,142,019
mixed-class rows
|
$3,891,028 | — | 01 Jun 2021 | |
| Alexandria Venture Investments, LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
2,645,985
|
$1,120,310 | — | 01 Jun 2021 | |
| Andrew Spaventa |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
22,873
|
$454,944 | — | 21 Feb 2025 | |
| Jorge Velarde |
3/4/5
|
Senior Vice President |
—
class O/S missing
|
340,000
|
$143,956 | — | 26 May 2021 | |
| Sam Ropp |
3/4/5
|
Chief Commercial Officer |
—
mixed-class rows
|
167,000
mixed-class rows
|
$138,368 | — | 15 Mar 2024 | |
| Dalen Meeter |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
6,000
|
$120,970 | — | 21 Feb 2025 | |
| Eli N. Glezer |
3/4/5
|
Chief Scientific Officer |
—
class O/S missing
|
6,000
|
$120,970 | — | 21 Feb 2025 | |
| Jyotsna Ghai |
3/4/5
|
Chief Operating Officer |
—
class O/S missing
|
3,000
|
$60,485 | — | 21 Feb 2025 | |
| Domain Partners IX, L.P. |
13D/G
|
— |
5%
|
125,446
|
$38,888 | $0 | 31 Dec 2024 | |
| Vincent Brancaccio |
3/4/5
|
Vice President, HR |
—
class O/S missing
|
32,500
|
$13,761 | — | 26 May 2021 |
Institutional Holders of Singular Genomics Systems, Inc. - Common Stock, par value $0.0001 per share (OMIC) as of Q3 2025
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q1 2025 Across Filers
| Investor | Q1 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.